✦ LIBER ✦

To widen the setting of cancer patients who could benefit from metronomic capecitabine

✍ Scribed by Margherita Nannini; Elisabetta Nobili; Roberto Di Cicilia; Giovanni Brandi; Alessandra Maleddu; Maria A. Pantaleo; Guido Biasco

Book ID: 105993081
Publisher: Springer
Year: 2009
Tongue: English
Weight: 241 KB
Volume: 64
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-009-0930-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The type of patients who would benefit f

The type of patients who would benefit from anti-androgen withdrawal therapy: could it be performed safely for aggressive prostate cancer?

✍ Kazuhiro Matsumoto, Nobuyuki Tanaka, Nozomi Hayakawa, Taisuke Ezaki… 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 192 KB

The role of cervical cerclage in obstetr

The role of cervical cerclage in obstetric practice: Can the patient who could benefit from this procedure be identified?

✍ Roberto Romero; Jimmy Espinoza; Offer Erez; Sonia Hassan 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 265 KB

Identification of patients who may benef

Identification of patients who may benefit from the prophylactic cranial radiotherapy among breast cancer patients with brain metastasis

✍ Pinar Saip; Irfan Cicin; Yesim Eralp; Hakan Karagol; Seden Kucucuk; Ruşen Cosar 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 201 KB

Somatic Mutations in BRCA1 and BRCA2 Cou

Somatic Mutations in BRCA1 and BRCA2 Could Expand the Number of Patients That Benefit From Poly (ADP Ribose) Polymerase Inhibitors in Ovarian Cancer

✍ Hennessy, B. T. J.; Timms, K. M.; Carey, M. S.; Gutin, A.; Meyer, L. A.; Flake, 📂 Article 📅 2010 🏛 American Society of Clinical Oncology 🌐 English ⚖ 182 KB

The Identification of a Subset of Patien

The Identification of a Subset of Patients with Axillary Node-Negative Minimally Invasive Breast Cancer Who May Benefit from Adjuvant Systemic Therapy

✍ Sandra A. Russo; Barbara Fowble; Kevin Fox; Lawrence J. Solin; Delray J. Schultz 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 793 KB

T3+ and T4 Rectal Cancer Patients Seem t

T3+ and T4 Rectal Cancer Patients Seem to Benefit From the Addition of Oxaliplatin to the Neoadjuvant Chemoradiation Regimen

✍ Ingrid S. Martijnse; Ralph L. Dudink; Miranda Kusters; Thomas A. Vermeer; Nichol 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 314 KB